Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Gastroenterology

• Publication date

  2015-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1053/j.gastro.2015.05.008PMID 25982290PMCID PMC4755303
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fecal Microbiota Transplantation Via Nasogastric Tube for Recurrent Clostridium difficile Infection in Pediatric Patients

  2015cited by this paper
• Burden of Clostridium difficile infection in the United States.

  2015cited by this paper
• Fecal Microbial Transplantation in Early-Onset Colitis: Caution Advised.

  2015cited by this paper
• Fecal Microbial Transplant Via Nasogastric Tube for Active Pediatric Ulcerative Colitis

  2015cited by this paper
• Fecal Microbial Transplant Effect on Clinical Outcomes and Fecal Microbiome in Active Crohn's Disease

  2015cited by this paper
• Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial.

  2015cited by this paper
• Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis.

  2015cited by this paper
• Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis.

  2014cited by this paper
• Fecal microbiota transplantation: a practical update for the infectious disease specialist.

  2014cited by this paper
• On the fiftieth anniversary Postinfectious irritable bowel syndrome: mechanisms related to pathogens

  2014cited by this paper
• Fecal microbiota transplantation: facts and controversies

  2014cited by this paper
• Fecal Microbiota Transplant for Treatment of Clostridium difficile Infection in Immunocompromised Patients

  2014cited by this paper
• Bacteremia as an adverse event of fecal microbiota transplantation in a patient with Crohn's disease and recurrent Clostridium difficile infection.

  2014cited by this paper
• Precision microbiome restoration of bile acid-mediated resistance to Clostridium difficile

  2014cited by this paper
• Rumen transfaunation.

  2014cited by this paper
• Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection

  2014cited by this paper
• Fecal Microbiota Transplantation in Children With Recurrent Clostridium difficile Infection

  2014cited by this paper
• Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection.

  2014cited by this paper
• Efficacy of combined jejunal and colonic fecal microbiota transplantation for recurrent Clostridium difficile Infection.

  2014cited by this paper
• P-003 New Diagnosis of Crohn’s Colitis 6 weeks After Fecal Microbiota Transplantation (FMT)

  2014cited by this paper
• Su1403 Single Colonoscopically Administered Fecal Microbiota Transplant for Ulcerative Colitis-A Pilot Study to Determine Therapeutic Benefit and Graft Stability

  2014cited by this paper
• Mo1228 Fecal Microbiota Transplantation Induces Early Improvement in Symptoms in Patients With Active Crohn's Disease

  2014cited by this paper
• Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study.

  2014cited by this paper
• Guidance on preparing an investigational new drug application for fecal microbiota transplantation studies.

  2014cited by this paper
• Physician attitudes toward the use of fecal microbiota transplantation for the treatment of recurrent Clostridium difficile infection.

  2014cited by this paper
• Fecal Transplant for Recurrent Clostridium difficile Infection in Children With and Without Inflammatory Bowel Disease

  2014cited by this paper
• The microbiome in inflammatory bowel disease: current status and the future ahead.

  2014cited by this paper
• Fecal Microbiota Transplantation for the Treatment of Clostridium difficile Infection: A Systematic Review

  2014cited by this paper
• The outcome and long-term follow-up of 94 patients with recurrent and refractory Clostridium difficile infection using single to multiple fecal microbiota transplantation via retention enema

  2014cited by this paper
• Faecal microbiota transplantation and bacteriotherapy for recurrent Clostridium difficile infection: A retrospective evaluation of 31 patients

  2014cited by this paper
• Cost-effectiveness analysis of treatment strategies for initial Clostridium difficile infection.

  2014cited by this paper
• PWE-078 A Prospective Controlled Pilot Study of Fecal Microbiota Transplantation for Chronic Refractory Pouchitis

  2013cited by this paper
• High-throughput DNA sequence analysis reveals stable engraftment of gut microbiota following transplantation of previously frozen fecal bacteria

  2013cited by this paper
• Patient Perceptions of Fecal Microbiota Transplantation for Ulcerative Colitis

  2013cited by this paper
• Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.

  2013cited by this paper
• Image of the month: “butterfly” effect, or mirror image, caused by a coiled esophageal manometry catheter.

  2013cited by this paper
• Faecal microbiota transplantation for severe Clostridium difficile infection in the intensive care unit.

  2013cited by this paper
• Norovirus Gastroenteritis After Fecal Microbiota Transplantation for Treatment of Clostridium difficile Infection Despite Asymptomatic Donors and Lack of Sick Contacts

  2013cited by this paper
• A comparison of human immunodeficiency virus, hepatitis C virus, hepatitis B virus, and human T‐lymphotropic virus marker rates for directed versus volunteer blood donations to the American Red Cross during 2005 to 2010

  2013cited by this paper
• Guidelines for Diagnosis, Treatment, and Prevention of Clostridium difficile Infections

  2013cited by this paper
• Fighting Obesity with Bacteria

  2013cited by this paper
• Safety, Tolerability, and Clinical Response After Fecal Transplantation in Children and Young Adults With Ulcerative Colitis

  2013cited by this paper
• Stool substitute transplant therapy for the eradication of Clostridium difficile infection: ‘RePOOPulating’ the gut

  2013cited by this paper
• Transient flare of ulcerative colitis after fecal microbiota transplantation for recurrent Clostridium difficile infection.

  2013cited by this paper
• Resolution of severe Clostridium difficile infection following sequential fecal microbiota transplantation.

  2013cited by this paper
• Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice

  2013cited by this paper
• Conserved Shifts in the Gut Microbiota Due to Gastric Bypass Reduce Host Weight and Adiposity

  2013cited by this paper
• Fecal microbiome transplantation for recurrent Clostridium difficile infection: report on a case series.

  2013cited by this paper
• The hypersensitivity to colonic distension of IBS patients can be transferred to rats through their fecal microbiota

  2013cited by this paper
• Complex interactions among diet, gastrointestinal transit, and gut microbiota in humanized mice.

  2013cited by this paper
• Fecal Microbiota Transplantation for Clostridium difficile Infection: Systematic Review and Meta-Analysis

  2013cited by this paper
• Temporal Bacterial Community Dynamics Vary Among Ulcerative Colitis Patients After Fecal Microbiota Transplantation

  2013cited by this paper
• Fecal microbiota transplant for recurrent Clostridium difficile infection: Mayo Clinic in Arizona experience.

  2013cited by this paper
• Duodenal infusion of donor feces for recurrent Clostridium difficile.

  2013cited by this paper
• Alteration of Intestinal Dysbiosis by Fecal Microbiota Transplantation Does not Induce Remission in Patients with Chronic Active Ulcerative Colitis

  2013cited by this paper
• Fecal microbiota transplantation for severe enterocolonic fistulizing Crohn's disease.

  2013cited by this paper
• Toward an Understanding of Changes in Diversity Associated with Fecal Microbiome Transplantation Based on 16S rRNA Gene Deep Sequencing

  2012cited by this paper
• Targeted Restoration of the Intestinal Microbiota with a Simple, Defined Bacteriotherapy Resolves Relapsing Clostridium difficile Disease in Mice

  2012cited by this paper
• Antibiotics in early life alter the murine colonic microbiome and adiposity

  2012cited by this paper
• Long-Term Follow-Up of Colonoscopic Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection

  2012cited by this paper
• Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infection.

  2012cited by this paper
• Intestinal microbiota in functional bowel disorders: a Rome foundation report

  2012cited by this paper
• Role of the microbiota in inflammatory bowel diseases.

  2012cited by this paper
• Fecal microbiota transplantation: techniques, applications, and issues.

  2012cited by this paper
• Suppression of Clostridium difficile in the Gastrointestinal Tracts of Germfree Mice Inoculated with a Murine Isolate from the Family Lachnospiraceae

  2012cited by this paper
• Should We Standardize the 1,700-Year-Old Fecal Microbiota Transplantation?

  2012cited by this paper
• A Canadian Working Group report on fecal microbial therapy: microbial ecosystems therapeutics.

  2012cited by this paper
• Standardized Frozen Preparation for Transplantation of Fecal Microbiota for Recurrent Clostridium difficile Infection

  2012cited by this paper
• Fecal Microbiota Transplantation for Relapsing Clostridium difficile Infection in 26 Patients: Methodology and Results

  2012cited by this paper
• Colonoscopic Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection in a Child

  2012cited by this paper
• Fecal microbiota transplantation for fulminant Clostridium difficile infection in an allogeneic stem cell transplant patient

  2012cited by this paper
• Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome.

  2012cited by this paper
• Editorial commentary: fecal microbiota transplantation: patient and physician attitudes.

  2012cited by this paper
• The interplay between the intestinal microbiota and the brain

  2012cited by this paper
• Fecal transplant via retention enema for refractory or recurrent Clostridium difficile infection.

  2012cited by this paper
• The Epidemiology of Community-Acquired Clostridium difficile Infection: A Population-Based Study

  2012cited by this paper
• Sa1922 Pilot Study on the Safety and Efficacy of Faecal Microbiota Transplantation in Refractory Crohn's Disease

  2012cited by this paper
• The gut microbiota in IBD

  2012cited by this paper
• Treating Clostridium difficile infection with fecal microbiota transplantation.

  2011cited by this paper
• Barriers to Greater Utilization of Fecal Bacteriotherapy for Chronic Clostridium difficile Infection: 368

  2010cited by this paper
• Success of self-administered home fecal transplantation for chronic Clostridium difficile infection.

  2010cited by this paper
• Fecal Bacteriotherapy for Relapsing Clostridium difficile Infection in a Child: A Proposed Treatment Protocol

  2010cited by this paper
• Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile

  2010cited by this paper
• Fecal Flora Reconstitution for Recurrent Clostridium difficile Infection: Results and Methodology

  2010cited by this paper
• Treatment of Refractory/Recurrent C. difficile-associated Disease by Donated Stool Transplanted Via Colonoscopy: A Case Series of 12 Patients

  2010cited by this paper
• Clostridium difficile infection: new developments in epidemiology and pathogenesis

  2009cited by this paper
• Faecal transplant for recurrent Clostridium difficile-associated diarrhoea: a UK case series.

  2009cited by this paper
• Changes in the Composition of the Human Fecal Microbiome After Bacteriotherapy for Recurrent Clostridium difficile-associated Diarrhea

  2009cited by this paper
• Successful treatment of fulminant Clostridium difficile infection with fecal bacteriotherapy.

  2008cited by this paper
• The Pervasive Effects of an Antibiotic on the Human Gut Microbiota, as Revealed by Deep 16S rRNA Sequencing

  2008cited by this paper
• Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea.

  2008cited by this paper
• Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

  2008cited by this paper
• Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases

  2007cited by this paper
• Ecological and evolutionary forces shaping microbial diversity in the human intestine.

  2006cited by this paper
• An obesity-associated gut microbiome with increased capacity for energy harvest

  2006cited by this paper
• Host-Bacterial Mutualism in the Human Intestine

  2005cited by this paper
• Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome--a longitudinal study in IBS and control subjects.

  2005cited by this paper
• Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe.

  2005cited by this paper
• Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact

  2005cited by this paper
• Analysis of the Fecal Microbiota of Irritable Bowel Syndrome Patients and Healthy Controls with Real-Time PCR

  2005cited by this paper

• Gut microbiome in colorectal cancer: recent advances and clinical implications

  2026cites this paper
• Microbiota Transplantation as a Future Novel Therapeutic Strategy Approach.

  2026cites this paper
• The present and future of fecal microbiota transplantation

  2026cites this paper
• The interplay between malnutrition, persistent diarrhea, lactose intolerance, and food associated gut dysbiosis in children; a comprehensive review

  2026cites this paper
• The Gut Mycobiome for Precision Medicine

  2025cites this paper
• Gut Microbiota Dysbiosis and Its Role in the Development of Irritable Bowel Syndrome

  2025cites this paper
• The heart of the matter: How gut microbiota-targeted interventions influence cardiovascular diseases.

  2025cites this paper
• Awareness and perception of fecal microbiota transplantation in Lebanon: a cross-sectional survey among the general population, healthcare workers, physicians, and patients

  2025cites this paper
• Exploring the Role of Gut Microbiota and Probiotics in Acute Pancreatitis: A Comprehensive Review

  2025cites this paper
• Síndrome do Intestino Irritável: abordagem baseada em evidências sobre fisiopatologia, diagnóstico e estratégias de manejo

  2025cites this paper
• Microbiota—A Rescuing Modulator in Children Struggling with Functional Constipation

  2025cites this paper
• MT-Tracker: A Phylogeny-Aware Algorithm for Quantifying Microbiome Transitions Across Scales and Habitats

  2025cites this paper
• A Review of Recent Advances in Fecal Microbiota Transplantation for the Treatment of Hepatic Encephalopathy

  2025cites this paper
• Bağırsak Mikrobiyotası ve Fekal Mikrobiyota Transplantasyonu: Klinik Uygulamalar ve Gelecek Perspektifleri

  2025cites this paper
• Case Report: Oral fecal microbiota transplantation in a Mediterranean spur-thighed tortoise (Testudo graeca) suffering from chronic gastrointestinal disease—procedure, clinical outcome and follow-up

  2025cites this paper
• Fecal Microbiota Therapy: Clinical Laboratory Testing and Metabolomic Approaches for Donor Screening, Product Assessment, and Patient Monitoring.

  2025cites this paper
• Pathobionts in the Microbiome: Drivers of Disease and Targets for Treatment.

  2025cites this paper
• Translating Patent Innovation into Clinical Practice: Two Decades of Therapeutic Advancements in Dysbiosis Management

  2025cites this paper
• Fecal microbiome transplantation in the treatment of chronic enteropathies.

  2025cites this paper
• Targeting the TLR4 axis with microbiota-oriented interventions and innovations in diabetes therapy: a narrative review

  2025cites this paper
• Advancing prostate cancer treatment: the role of fecal microbiota transplantation as an adjuvant therapy

  2025cites this paper
• Probiotics Ameliorate Histological Alterations and Prevent Increases in Cytokine and Toxin Levels in Mice Infected with Various Clostridioides difficile Strains.

  2025cites this paper
• Advances in Fecal Microbiota Transplantation for Gut Dysbiosis‐Related Diseases

  2025cites this paper
• Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): the interplay of gut microbiome, insulin resistance, and diabetes

  2025cites this paper
• The Gut Microbiome in Human Obesity: A Comprehensive Review

  2025cites this paper
• Microbiome editing in infectious disease prevention and therapy: CRISPR Applications in Host-Microbe Interactions

  2025cites this paper
• The probiotic enhances donor microbiota stability and improves the efficacy of fecal microbiota transplantation for treating colitis

  2025cites this paper
• Demystifying the Association of the Gut–TMAO–Heart Axis: Focusing on Gut Microbiota in Myocardial Infarction

  2025cites this paper
• Safety and efficacy of faecal microbiota transplantation in patients with acute uncomplicated diverticulitis: study protocol for a randomised placebo-controlled trial

  2025cites this paper
• Impact of fecal microbiota transplantation in dogs

  2025cites this paper
• Fecal Microbiota Transplantation as an Alternative Method in the Treatment of Obesity

  2025influential citation
• The microbiome’s hidden influence: preclinical insights into inflammatory responses in necrotizing enterocolitis

  2025cites this paper
• Patient-donor similarity and donor-derived species contribute to the outcome of faecal microbiota transplantation for ulcerative colitis.

  2025cites this paper
• Clinical analysis of fecal microbiota transplantation for refractory acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a five-year retrospective study.

  2025cites this paper
• A “movement” worth making: why and how Transfusion Services can play a role in Fecal Microbiota Transplant programs

  2025cites this paper
• Therapeutic potential of fecal microbiota transplantation in colorectal cancer based on gut microbiota regulation: from pathogenesis to efficacy

  2025cites this paper
• Gut microbiome‐targeted therapies as adjuvant treatments in inflammatory bowel diseases: a systematic review and network meta‐analysis

  2024cites this paper
• Gut microbiota has important roles in the obstructive sleep apnea-induced inflammation and consequent neurocognitive impairment

  2024cites this paper
• The gut microbiota improves reproductive dysfunction in obese mice by suppressing the NLRP3/ASC/caspase-1 axis.

  2024cites this paper
• Factors for Treatment Failure After Fecal Microbiota Transplantation in Clostridioides difficile Infection

  2024cites this paper
• Determining the optimal route of faecal microbiota transplant in patients with ulcerative colitis: the STOP-Colitis pilot RCT

  2024cites this paper
• Efficacy of Donor-Recipient-Matched Faecal Microbiota Transplantation in Patients with IBS-D: A Single-Centre, Randomized, Double-Blind Placebo-Controlled Study

  2024cites this paper
• Fecal Microbiota Transplantation Regulates Blood Pressure by Altering Gut Microbiota Composition and Intestinal Mucosal Barrier Function in Spontaneously Hypertensive Rats

  2024cites this paper
• Exploring the Role of Gut Microbiome in Chronic Inflammatory Diseases: A Comparative Study

  2024cites this paper
• Fecal microbiota transplantation as a possibility of curing Irritable Bowel Syndrome FMT as a possibility of curing IBS

  2024cites this paper
• Recent advances in fecal microbiota transplantation for Clostridium difficile infection-associated diarrhea after kidney transplantation

  2024cites this paper
• Understanding the complex function of gut microbiota: its impact on the pathogenesis of obesity and beyond: a comprehensive review

  2024cites this paper
• The Role of Fecal Microbiota Transplantation in IBD

  2024cites this paper
• Efficacy and safety of fecal microbiota transplantation for treatment of ulcerative colitis: A post-consensus systematic review and meta-analysis

  2024cites this paper
• Effects of Retrograde Colonic Enema-Based Fecal Microbiota Transplantation in the Treatment of Childhood Constipation: A Randomized, Double-Blind, Controlled Trial

  2024cites this paper
• Fecal microbiota transplantation: current challenges and future landscapes

  2024cites this paper
• Safety profile and effects on the peripheral immune response of fecal microbiota transplantation in clinically healthy dogs

  2024cites this paper
• Clinical effects of chemical drugs, fecal microbiota transplantation, probiotics, dietary fiber, and acupuncture in the treatment of chronic functional constipation: a systematic review and network meta-analysis

  2024cites this paper
• Targeted modulation of gut and intra-tumor microbiota to improve the quality of immune checkpoint inhibitor responses.

  2024cites this paper
• Fecal microbiome composition and diversity of cryopreserved canine stool at different duration and storage conditions

  2024cites this paper
• Exploring the complexities of megacystis-microcolon-intestinal hypoperistalsis syndrome: insights from genetic studies

  2024cites this paper
• Dietary α-linolenic acid supplementation enhances resistance to Salmonella Typhimurium challenge in chickens by altering the intestinal mucosal barrier integrity and cecal microbes.

  2024cites this paper
• Fecal microbiota transplantation and next-generation therapies: A review on targeting dysbiosis in metabolic disorders and beyond

  2024cites this paper
• The gut microbiome and nonalcoholic fatty liver disease: prospects for drug therapy

  2024cites this paper
• Maternal F-53B exposure during pregnancy and lactation induced glucolipid metabolism disorders and adverse pregnancy outcomes by disturbing gut microbiota in mice.

  2024cites this paper
• Faecal microbial transplant

  2024cites this paper
• Microbiota transplantation

  2024cites this paper
• To Determine the Frequency of Clinical Remission Induction with Versus without Fecal Microbiota Transplant in Treatment of Active Ulcerative Colitis

  2024cites this paper
• Fecal Microbiota Transplantation: A Prospective Treatment for Type 2 Diabetes Mellitus

  2024cites this paper
• Strategy for Comprehensive Detection and Annotation of Gut Microbiota-Related Metabolites Based on Liquid Chromatography-High-Resolution Mass Spectrometry.

  2024cites this paper
• Gut microbiota, microbiota‐derived metabolites, and graft‐versus‐host disease

  2024cites this paper
• Faecal microbiota transplantation (FMT) in Norwegian outpatients with mild to severe myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): protocol for a 12-month randomised double-blind placebo-controlled trial

  2024cites this paper
• Microbiota Transplantation as an Adjunct to Standard Periodontal Treatment in Periodontal Disease: A Systematic Review

  2024cites this paper
• Fecal microbiota transplantation for treatment of non-alcoholic fatty liver disease: Mechanism, clinical evidence, and prospect

  2024cites this paper
• Gut microbiota and prospects for probiotics in paediatric celiac disease

  2024cites this paper
• Evaluation of Bacterial Viability for Fecal Microbiota Transplantation: Impact of Thawing Temperature and Storage Time

  2024cites this paper
• Prevention and control strategies for antibiotic resistance: from species to community level

  2024cites this paper
• Insights into the Evolving Epidemiology of Clostridioides difficile Infection and Treatment: A Global Perspective

  2023cites this paper
• Male‐Biased Gut Microbiome and Metabolites Aggravate Colorectal Cancer Development

  2023cites this paper
• Exploring the complex and multifaceted interplay of the gut microbiome and cancer prevention and therapy.

  2023cites this paper
• Fecal microbiota transplantation for the treatment of irritable bowel syndrome: A systematic review and meta-analysis

  2023cites this paper
• Fecal transplantation for treatment of inflammatory bowel disease.

  2023cites this paper
• Gut microbiome, metabolome, host immunity associated with inflammatory bowel disease and intervention of fecal microbiota transplantation.

  2023cites this paper
• Relationship between Gut Microbiota and Allergies in Children: A Literature Review

  2023cites this paper
• Repeated and multiple fecal microbiota transplantations plus partial enteral nutrition as the first-line treatment in active pediatric Crohn’s disease

  2023cites this paper
• Exploring the Potential of Probiotics and Fecal Microbiota in Maintaining a Healthy Gut Microbiota

  2023cites this paper
• [Faecal microbiota transplantation is a simple, effective and safe treatment in the management of C. difficile infection in daily clinical practice].

  2023cites this paper
• Fecal Microbiota Transplantation Research over the Past Decade: Current Status and Trends

  2023cites this paper
• Depletion of butyrate-producing microbes of the Firmicutes predicts nonresponse to FMT therapy in patients with recurrent Clostridium difficile infection

  2023cites this paper
• Fecal Microbiota Transplantation for Fulminant Clostridioides Difficile Infection: A Combined Medical and Surgical Case Series

  2023cites this paper
• Gut microbes in metabolic disturbances. Promising role for therapeutic manipulations?

  2023cites this paper
• Gut Microbiota Alteration and Its Modulation with Probiotics in Celiac Disease

  2023cites this paper
• Role of Fecal Microbiota Transplantation in Managing Clostridium Difficile Infection and Inflammatory Bowel Disease: A Narrative Review

  2023cites this paper
• Development of Gut Microbiota in the First 1000 Days after Birth and Potential Interventions

  2023cites this paper
• Fecal microbiota transplantation in a child with severe ASD comorbidities of gastrointestinal dysfunctions—a case report

  2023cites this paper
• Management of obesity and other metabolic disorders through faecal microbiota transplant technology

  2023cites this paper
• Oral fecal transplantation enriches Lachnospiraceae and butyrate to mitigate acute liver injury.

  2023cites this paper
• A meta-analysis of microbiome therapies for hepatic encephalopathy

  2023cites this paper
• Manipulation of the intestinal microbiome-a slow journey to primetime

  2023cites this paper
• The Significance of Dysbiosis in the Gut Microbiome to HCV Infection and Disease Progression

  2023cites this paper
• Colonization of the Gastrointestinal Tract of Chicks with Different Bacterial Microbiota Profiles

  2023cites this paper
• Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile).

  2023cites this paper
• Fecal microbiota transplantation in childhood: past, present, and future

  2022cites this paper
• The Role of the Gut Microbiome in Pediatric Obesity and Bariatric Surgery

  2022cites this paper
• The Effects of Multi-Donor Fecal Microbiota Transplantation Capsules Combined with Thalidomide on Hormone-Dependent Ulcerative Colitis

  2022cites this paper